Fig. 7.
Effect of anti-Id–IL-2 therapy on animals with more established tumors. Syngeneic mice C3H/HeN (n = 10) were inoculated SC with 1 × 103 tumor cells. Treatment with the chS5A8–IL-2 fusion protein was started 1, 3, or 7 days after tumor inoculation. Animals treated with PBS on day 1 were included as controls. The mean tumor volume of each group was calculated. SDs (bars) are only given at day 20 for clarity.
